搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD) CSB-YP817863LOS
CSB-EP817863LOS
CSB-BP817863LOS
CSB-MP817863LOS
CSB-EP817863LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai NADH-quinone oxidoreductase subunit B (nuoB) CSB-YP817864LOS
CSB-EP817864LOS
CSB-BP817864LOS
CSB-MP817864LOS
CSB-EP817864LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai LL-diaminopimelate aminotransferase (dapL) CSB-YP817865LOS
CSB-EP817865LOS
CSB-BP817865LOS
CSB-MP817865LOS
CSB-EP817865LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai Quinolinate synthase A (nadA) CSB-YP817866LOS
CSB-EP817866LOS
CSB-BP817866LOS
CSB-MP817866LOS
CSB-EP817866LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP817867LOS
CSB-EP817867LOS
CSB-BP817867LOS
CSB-MP817867LOS
CSB-EP817867LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai 7-cyano-7-deazaguanine synthase (queC) CSB-YP817868LOS
CSB-EP817868LOS
CSB-BP817868LOS
CSB-MP817868LOS
CSB-EP817868LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai tRNA (Ile)-lysidine synthase (tilS) CSB-YP817869LOS
CSB-EP817869LOS
CSB-BP817869LOS
CSB-MP817869LOS
CSB-EP817869LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai DNA replication and repair protein recF (recF) CSB-YP817870LOS
CSB-EP817870LOS
CSB-BP817870LOS
CSB-MP817870LOS
CSB-EP817870LOS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UPF0391 membrane protein ytjA (ytjA), partial CSB-YP817871EGX
CSB-EP817871EGX
CSB-BP817871EGX
CSB-MP817871EGX
CSB-EP817871EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Endoribonuclease symE (symE) CSB-YP817872EGX
CSB-EP817872EGX
CSB-BP817872EGX
CSB-MP817872EGX
CSB-EP817872EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 3' (2'),5'-bisphosphate nucleotidase CysQ (cysQ) CSB-YP817873EGX
CSB-EP817873EGX
CSB-BP817873EGX
CSB-MP817873EGX
CSB-EP817873EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Quaternary ammonium compound-resistance protein sugE (sugE), partial CSB-YP817874EGX1
CSB-EP817874EGX1
CSB-BP817874EGX1
CSB-MP817874EGX1
CSB-EP817874EGX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UvrABC system protein A (uvrA), partial CSB-YP817875EGX
CSB-EP817875EGX
CSB-BP817875EGX
CSB-MP817875EGX
CSB-EP817875EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maltose/maltodextrin import ATP-binding protein MalK (malK) CSB-YP817876EGX
CSB-EP817876EGX
CSB-BP817876EGX
CSB-MP817876EGX
CSB-EP817876EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP817877EGX
CSB-EP817877EGX
CSB-BP817877EGX
CSB-MP817877EGX
CSB-EP817877EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phosphoenolpyruvate carboxylase (ppc), partial CSB-YP817878EGX
CSB-EP817878EGX
CSB-BP817878EGX
CSB-MP817878EGX
CSB-EP817878EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhamnulose-1-phosphate aldolase (rhaD) CSB-YP817879EGX
CSB-EP817879EGX
CSB-BP817879EGX
CSB-MP817879EGX
CSB-EP817879EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) CSB-YP817880EGX
CSB-EP817880EGX
CSB-BP817880EGX
CSB-MP817880EGX
CSB-EP817880EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ribose import ATP-binding protein RbsA (rbsA) CSB-YP817881EGX
CSB-EP817881EGX
CSB-BP817881EGX
CSB-MP817881EGX
CSB-EP817881EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tryptophanase (tnaA) CSB-YP817882EGX
CSB-EP817882EGX
CSB-BP817882EGX
CSB-MP817882EGX
CSB-EP817882EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>